India, the second-most populous country in the world is witnessing a daily surge in the COVID-19 infected cases. India is currently among the worst-hit nations worldwide due to the COVID-19 pandemic and ranks just behind Brazil and the USA. The prediction of the future course of the pandemic is thus of utmost importance in order to prevent further worsening of the situation. In this paper, we develop models for the past trajectory (March 01, 2020-July 25, 2020) and also make a month-long (July 26, 2020-August 24, 2020) forecast of the future evolution of the COVID-19 pandemic in India by using an autoregressive integrated moving average (ARIMA) model. We determine the most optimal ARIMA model (ARIMA(7,2,2)) based on the statistical parameters viz. root-mean-squared error (RMSE), mean absolute error (MAE), mean absolute percentage error (MAPE), and the coefficient of determination (R 2). Subsequently, the developed model is used to obtain a one month-long forecast for the cumulative cases, active cases, recoveries, and the number of fatalities. According to our forecasting results, India is likely to have 3800,989 cumulative infected cases, 1634,142 cumulative active cases, 2110,697 cumulative recoveries, and 56,150 cumulative deaths by August 24, 2020, if the current trend of the pandemic continues to prevail. The implications of these forecasts are that in the upcoming month, the infection rate of COVID-19 in India is going to escalate, while the rate of recovery and the case-fatality rate is likely to reduce. In order to avert these possible scenarios, the administration and health-care personnel need to formulate and implement robust control measures, while the general public needs to be more responsible and strictly adhere to the established and newly formulated guidelines in order to slow down the spread of the pandemic and prevent it from transforming into a catastrophe.
India, the second-most populous country in the world, has been lately witnessing a daily surge in the COVID-19 infected cases. India is currently among the worst-hit nations worldwide, due to the COVID-19 pandemic, and ranks just behind Brazil and USA. In order to prevent the further worsening of the situation, predicting the future course of the pandemic is of utmost importance. In this paper, we model the past trajectory (March 01, 2020 - July 25, 2020) and make a month-long (July 26, 2020 - August 24, 2020) forecast of the future evolution of the COVID-19 pandemic in India using an autoregressive integrated moving average (ARIMA) model. According to our forecasting results, India is likely to have 3,800,989 cumulative infected cases, 1,634,142 cumulative active cases, 2,110,697 cumulative recoveries and 56,150 cumulative deaths by August 24, 2020, if the current trend of the pandemic continues to prevail. The implications of these forecasts are that in the upcoming month the infection rate of COVID-19 in India is going to escalate, while as the rate of recovery and the case-fatality rate is likely to reduce. In order to avert these possible scenarios, the administration and health-care personnel need to formulate and implement robust control measures, while the general public needs to be more responsible and strictly adhere to the established and newly formulated guidelines to slow down the spread of the pandemic and prevent it from transforming into a catastrophe.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.